Recent Finacing
Recent Raise
Genocea is a Cambridge-based clinical-stage biotechnology company developing T cell–based vaccines using its ATLAS antigen-discovery platform, advancing therapeutic HSV-2 and prophylactic programs for pneumococcus, chlamydia, and malaria.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
